Advertisement
Advertisement
VRDN
Viridian Therapeutics, Inc. Common Stock
17.04
USDSponsored
+0.18
+1.07%
May 13, 16:00 UTC -4
Closed
Pre-Market
17.60
+0.56
+3.30%
Viridian Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 1.81B |
| Beta | 1.16 |
| Earnings Per Share (EPS) | -3.29 |
| Price-to-Book (P/B) Ratio | 2.49 |
| Operating Margin | -483.57% |
| Total Debt/Equity (D/E) | 6.92% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -83.25% |
| Current Ratio | 12.65% |
| Free Cash Flow | -276.89M |
Trending Stocks
Advertisement